SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-002016
Filing Date
2023-01-10
Accepted
2023-01-10 16:05:39
Documents
14
Period of Report
2023-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171397-8k_somalogic.htm   iXBRL 8-K 34962
2 AMENDMENT NO. 2 TO MASTER COLLABORATION AGREEMENT, DATED AS OF JANUARY 4, 2023, ea171397ex10-1_somalogic.htm EX-10.1 47297
  Complete submission text file 0001213900-23-002016.txt   312256

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE slgc-20230104.xsd EX-101.SCH 4074
4 XBRL DEFINITION FILE slgc-20230104_def.xml EX-101.DEF 26767
5 XBRL LABEL FILE slgc-20230104_lab.xml EX-101.LAB 37000
6 XBRL PRESENTATION FILE slgc-20230104_pre.xml EX-101.PRE 25391
8 EXTRACTED XBRL INSTANCE DOCUMENT ea171397-8k_somalogic_htm.xml XML 5750
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 23521183
SIC: 8731 Services-Commercial Physical & Biological Research